Answers are grounded in this paper and cite their sources.
Article Abstract Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text. To the Editor: Bipolar depression is a leading cause of disability in the United States. Recently, N-methyl-d-asparate glutamate-receptor (NMDAR) antagonists, such as ketamine, have been shown to induce remission in bipolar depression. Nevertheless, ketamine use is limited by transient effects and psychogenic potential during repeated administration. d-Cycloserine is a US Food and Drug Administration (FDA)-approved antituberculosis drug that acts as an NMDAR antagonist when used at high doses (> 750 mg).
No takes yet. Share an insight, caveat, or question.
Kantrowitz et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: